Hospira, Inc. Recalls One Lot of Electrolyte Solution After Mold Found
Published: Jan 29, 2013
Hospira Inc is recalling one lot of an intravenous electrolyte solution after the discovery of the presence of a substance that was consistent with mold, U.S. health regulators said on Monday. The Food and Drug Administration said the affected lot of the product, known as Lactated Ringer's and 5% Dextrose Injection, was distributed nationwide between June 2011 and January 2012 to wholesalers, hospitals and pharmacies. The FDA said the substance in the solution was discovered by a Hospira customer. The customer was not identified. Electrolyte solutions are used to replenish fluids and calories.